Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P MoriceD Castaigne

Abstract

The aim of the study was to determine the value and the costs of routine follow-up for the detection of recurrences in patients treated for endometrial cancer. Between 1986 and 1995, 390 women with clinical stage I/II endometrial carcinoma were treated with combined surgery-radiation therapy. After treatment, follow-up was based on the clinical examination, a systematic Papanicolaou (Pap) smear and radiography (chest X-ray and abdomino-pelvic ultrasonography). 27 patients relapsed: 22 patients had symptoms and 5 were asymptomatic. None of the patients had recurrence detected on the routine Pap smear nor on the systematic chest X-ray. In conclusion, the follow-up of patients treated for endometrial cancer based on routine Pap smears and systematic radiography does not permit earlier detection of recurrences. Follow-up should simply include a clinical examination whose frequency should be based on prognostic factors. Approximately two-thirds of this cost was due to systematic examinations (Pap smears and radiography). Our results indicate that such expenditure could be avoided.

References

Apr 15, 1985·American Journal of Obstetrics and Gynecology·P J DiSaiaJ A Blessing
Jan 1, 1996·Acta Obstetricia Et Gynecologica Scandinavica·L A Møller, S A Engelholm
Jul 1, 1996·British Journal of Obstetrics and Gynaecology·P Owen, I D Duncan
Aug 29, 1996·The New England Journal of Medicine·P G Rose
Jul 15, 1996·International Journal of Radiation Oncology, Biology, Physics·O AlganR M Lanciano
Jan 1, 1997·British Journal of Obstetrics and Gynaecology·J R AllsopS Crocker
Dec 31, 1997·British Journal of Obstetrics and Gynaecology·H B SalvesenO E Iversen
Aug 19, 2005·Journal de gynécologie, obstétrique et biologie de la reproduction·B TrétarreJ P Daurès

❮ Previous
Next ❯

Citations

Apr 29, 2010·International Journal of Clinical Oncology·Yutaka UedaTadashi Kimura
Oct 4, 2012·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Frédéric AmantCarien L Creutzberg
Oct 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A GietemaW T A van der Graaf
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·W A A TjalmaD J Cruickshank
May 11, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F M KewD J Cruickshank
May 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F M KewL Verleye
May 1, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P ZolaE Sartori
Jul 9, 2010·Obstetrics and Gynecology International·Ying Zhang, Jian Wang
Sep 23, 2014·Health Technology Assessment : HTA·Tristan SnowsillChris Hyde
Mar 11, 2009·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·F M KewH Manderville
Oct 22, 2014·Expert Opinion on Emerging Drugs·Giulia AmadioGiovanni Scambia
May 3, 2012·Acta Obstetricia Et Gynecologica Scandinavica·Henrik LajerOle Mogensen
Mar 9, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Ingvild VistadAstrid H Liavaag
Sep 1, 2004·Journal of the American Academy of Dermatology·Timothy S WangJennifer L Schwartz
Jun 27, 2006·Gynecologic Oncology·Robert E BristowRobert L Giuntoli
Mar 25, 2006·Gynecologic Oncology·Michael Fung-Kee-FungUNKNOWN Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group
Aug 9, 2005·Lancet·Frederic AmantIgnace Vergote
Apr 4, 2015·Gynecologic Oncology·Jessica HunnS Diane Yamada
Aug 9, 2011·Gynecologic Oncology·Ritu SalaniRobert E Bristow
Jul 3, 2016·American Journal of Clinical Pathology·Chengquan ZhaoR Marshall Austin
Jan 31, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Lilly AungPeter W Jones
Sep 20, 2018·BJOG : an International Journal of Obstetrics and Gynaecology·Joanna Tegnerowicz
Jul 29, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jung-Yun LeeYong-Sang Song
May 8, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Eva PaganoGiovannino Ciccone
Jun 19, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Luisa CarraraEnrico Sartori
Jul 25, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Paolo ZolaVesna Kesic
Aug 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Enrico SartoriPaolo Zola
Feb 9, 2016·Obstetrics and Gynecology·Jason D WrightDawn L Hershman
May 17, 2019·Current Oncology Reports·Mette Moustgaard JeppesenPernille T Jensen
May 8, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Sarah Coleridge, Jo Morrison
Aug 11, 2017·Acta Obstetricia Et Gynecologica Scandinavica·Ingvild VistadAnne Dørum
Jun 12, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Iqra LuqmanEsther L Moss
Mar 24, 2009·Obstetrics and Gynecology·Janice S KwonEva Grunfeld
Dec 9, 2015·International Journal of Nursing Practice·Hiroko KomatsuToru Takebayashi
Jan 30, 2021·Revista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia·Amina LubranoLaureano Leon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
W A A TjalmaD J Cruickshank
Gynecologic Oncology
Michael Fung-Kee-FungCancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group
© 2021 Meta ULC. All rights reserved